In one of the largest settlements ever secured by a whistleblower under the False Claims Act, the multinational pharmaceutical corporation Biogen agreed to pay $900 million in order to end a lawsuit related to an illegal kickback program.
Attorneys general in 20 states sued six generic drug makers for conspiring to increase prices on generic medications to boost profits.
WikiLeaks Publishes Finalized TPP Chapter Which Expands Monopoly Rights for Pharmaceutical Companies
Days after secretive negotiations on the Trans-Pacific Partnership concluded, WikiLeaks has published the complete chapter on intellectual property. The leaked text shows the TPP would expands monopoly rights for pharmaceutical companies to help protect against competition from generic drug manufacturers. According to an analysis by Public Citizen, the text also